These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 16336564)
1. Non-immunologic intervention in chronic allograft nephropathy. Arias M; Fernández-Fresnedo G; Rodrigo E; Ruiz JC; González-Cotorruelo J; Gómez-Alamillo C Kidney Int Suppl; 2005 Dec; (99):S118-23. PubMed ID: 16336564 [TBL] [Abstract][Full Text] [Related]
2. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction. Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092 [TBL] [Abstract][Full Text] [Related]
3. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion. Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436 [TBL] [Abstract][Full Text] [Related]
4. Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study. Iñigo P; Campistol JM; Saracho R; Del Castillo D; Anaya F; Esforzado N; Navarro MD; Oppenheimer F Nephron Clin Pract; 2003; 95(3):c84-90. PubMed ID: 14646368 [TBL] [Abstract][Full Text] [Related]
5. [Changes in renal function in renal transplantation. Predictive factors for functional deterioration]. Jiménez del Cerro LA; Franco A; Rivera F; Olivares J Nefrologia; 2001; 21(3):295-304. PubMed ID: 11471310 [TBL] [Abstract][Full Text] [Related]
6. Chronic allograft dysfunction in kidney transplant recipients: long-term single-center study. Boratyńska M; Wakulenko A; Klinger M; Szyber P Transplant Proc; 2014 Oct; 46(8):2673-7. PubMed ID: 25380892 [TBL] [Abstract][Full Text] [Related]
7. [Post-transplant nephropathy and arterial hypertension]. Oko A; Idasiak-Piechocka I; Czekalski S Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248 [TBL] [Abstract][Full Text] [Related]
8. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696 [TBL] [Abstract][Full Text] [Related]
9. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
10. Chronic rejection of renal transplants: new clinical insights. Vazquez MA Am J Med Sci; 2000 Jul; 320(1):43-58. PubMed ID: 10910373 [TBL] [Abstract][Full Text] [Related]
11. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study. Drechsler C; Pihlstrøm H; Meinitzer A; Pilz S; Tomaschitz A; Abedini S; Fellstrom B; Jardine AG; Wanner C; März W; Holdaas H Transplantation; 2015 Jul; 99(7):1470-6. PubMed ID: 25675199 [TBL] [Abstract][Full Text] [Related]
12. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
14. Non-immune interventions to protect kidney allografts in the long term. Cravedi P; Perico N; Remuzzi G Kidney Int Suppl; 2010 Dec; (119):S71-5. PubMed ID: 21116322 [TBL] [Abstract][Full Text] [Related]
15. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; Marcantoni C; de Jong PE; de Zeeuw D; Shahinfar S; Ruggenenti P; Remuzzi G; Levey AS; Kidney Int; 2001 Sep; 60(3):1131-40. PubMed ID: 11532109 [TBL] [Abstract][Full Text] [Related]